Poster Abstract Session:
232. Clinical: Bacteremia and Endocarditis
Saturday, October 7, 2017: 12:30 PM-2:00 PM
Room: Poster Hall CD


Presentations:
Twenty-One Years of Staphylococcus aureus Bacteremia (SAB): Variations in Bacterial Genotype and Clinical Phenotype in the S. aureus Bacteremia Group Prospective Cohort Study (SABG-PCS) from 1995 to 2015
Maria Souli, MD PhD; Felicia Ruffin, MSN, RN; Lawrence Park, PhD; Batu K Sharma-Kuinkel, PhD; Joshua T. Thaden, MD, PhD; Stacey Maskarinec, MD, PhD; Shengli Gao, MD; Nicholas Christopoulos Lent, Researcher; Lisa Wanda, BS, BA; Jonathan Hill-Rorie, BA; Bobby Warren, MPS; Brenda Hansen, M.S.; Vance G. Fowler Jr., MD
Posters
  • Maria Souli.pdf (801.8 kB)
  • A Prospective Study of Enterococcal Bacteremia in Cancer vs. Non-Cancer Populations: One Disease, Two Tales
    Jose M. Munita, MD; German Contreras, MD MSc; Pranoti Sahasrabhojane, MS; Gabriela Sanchez Petitto, MD; Rafael Araos, MD, MMSc; Audrey Wanger, PhD; Samuel L. Aitken, PharmD; Samuel A. Shelburne, MD, PhD; Cesar Arias, MD, PhD, FIDSA
    Blood Stream Infection in LVAD Recipients: More than Meets the Eye
    Simi Philip, MD; Edward Chapnick, MD, FIDSA, FSHEA; Monica Ghitan, MD, FIDSA; Yu Shia Lin, MD; Margaret Kuhn-Basti, M.D.
    Utility of 18F-FDG PET/CT in Evaluation of Staphylococcus aureus Bacteremia
    Maryam Mahmood, MD; A. Tuba Kendi, MD; Bharath Raj Palraj, MBBS; Geoffrey B. Johnson, MD PhD; Saira Farid, MD; M. Rizwan Sohail, MD
    Posters
  • IDwk SAB_final.pdf (503.2 kB)
  • Utility of Prior Cultures in Predicting Antibiotic Resistance of Bloodstream Infections Due to Gram-negative Pathogens
    Derek Macfadden, MD; Bryan Coburn, MD; Nirav Shah, MD; Ari Robicsek, MD; Rachel Savage, MSc; Marion Elligsen, RPh; Nick Daneman, MD, MSc
    Clinical and Economic Comparison of Ceftaroline Fosamil (CPT) and Daptomycin (DAP) for Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections (BSI)
    Evan J. Zasowski, PharmD, MPH, BCPS; Trang D. Trinh, PharmD, MPH, BCPS, AAHIVP; Kimberly Claeys, PharmD, BCPS; Abdalhamid M. Lagnf, MPH; Kenneth Klinker, PharmD; Sandy Estrada, Pharm.D., BCPS (AQ-ID); Susan L Davis, PharmD; Vanthida Huang, PharmD; Brian A. Potoski, PharmD; Donald Levine, MD; Keith S. Kaye, MD, MPH; Nicole Bonine, PhD, MPH; Patrick Gillard, PharmD, MS; Michael J. Rybak, PharmD, MPH, PhD
    Posters
  • Slide1.GIF (910.9 kB)
  • Predictors and Clinical Implications of Bloodstream Infections in Continuous Flow Left Ventricular Assist Device Recipients: A Single Institutional Experience of 212 Patients
    Andreas Kyvernitakis, MD; Orestis Pappas, MD; Dimitrios Farmakiotis, MD, FACP; Parag Mahale, MBBS, PhD, MPH; Edward Horn, Pharm D; Srinivas Murali, MD; Raymond Benza, MD; Stephen Bailey, MD; Richa Agarwal, MD
    Development and Validation of a Risk Prediction Score For Enterococcal Endocarditis
    Caline Mattar, M.D; Benjamin S. Thomas, M.D.; Fiona Strasserking, M.D; Faris Bakeer, M.D; Jeffrey Chung, M.D; David Warren, MD, MPH
    Decreasing Numbers of Blood Cultures: Does it Matter?
    Kenneth Rand, MD; Stacy Beal, MD; Thomas Payton, MD; Brandon Allen, MD; Kimberly Rivera, n/a
    Posters
  • IDWeek poster ver 4 final .pdf (582.6 kB)
  • Sequence type 393 associated with increased mortality in Escherichia coli bloodstream infections
    Joshua T. Thaden, MD, PhD; Granger Sutton, PhD; Felicia Ruffin, MSN, RN; Derrick Fouts, PhD; Vance G. Fowler Jr., MD
    Sensitivity and Specificity of Duke Criteria for Diagnosis of Definite Infective Endocarditis: A Cohort Study
    Nabin Shrestha, MD, MPH, FIDSA, FSHEA; Sampurna Shakya, MD; Syed Hussain, MD; Gosta Pettersson, MD, PhD; Brian Griffin, MD; Steven Gordon, MD
    Posters
  • ie_duke_criteria_poster.pdf (88.2 kB)
  • Colonic Lesions in Patients with Enterococcal Endocarditis
    Prasanna Sengodan, MD; Prashanthi Thota, MD; Tannaz Asadi, MD; Steven Gordon, MD; Kv Gopalakrishna, MD; Nabin Shrestha, MD, MPH, FIDSA, FSHEA
    Infective Endocarditis in a Tertiary-Center in Jerusalem, an 8-Year Prospective Survey: Effects of Surgery on Mortality
    Lidor Peretz, Student; Amit Korach, MD; Maya Korem, MD; Sarah Israel, MD; Dan Gilon, MD; Allon Moses, MD; Jacob Strahilevitz, MD
    Escherichia coli ST131 is Associated With Increased Mortality In Bloodstream Infections From Urinary Tract Source
    Amanda Brumwell, BS; Joshua T. Thaden, MD, PhD; Paul Lantos, MD, FIDSA; Kate Hoffman, PhD; Felicia Ruffin, MSN, RN; Vance G. Fowler Jr., MD
    Posters
  • ANB_id1905_2107.png (132.5 kB)
  • Recurrent Enterococcal Bloodstream Infection in Patients with Acute Leukemia
    Julia Messina, MD; Anthony Sung, MD; Barbara D. Alexander, MD, MHS, FIDSA; Nelson Chao, MD, MBA
    Posters
  • IDSA Poster_9-22-17 .pdf (970.6 kB)
  • Clinical characteristics of invasive disease caused by a rare Group A Streptococcus subtype (emm26.3) — Alaska, 2016–2017
    Emily Mosites, PhD MPH; Anna Frick, MPH; Prabhu Gounder, MD MPH; Louisa Castrodale, DVM; Karen Rudolph, PhD; K. Danielle Lecy, BSN; Tammy Zulz, MPH; Joseph Mclaughlin, MD; Thomas Hennessy, MD, MPH; Michael Bruce, MD, MPH
    Clinical Practice Variation in the Management of Staphylococcus aureus Bacteremia: Results from an Emerging Infections Network Survey
    Luke Strnad, MD; Susan E. Beekmann, RN, MPH; Philip M. Polgreen, MD; Henry Chambers, MD, FIDSA; Catherine Liu, MD, FIDSA
    Sero-Epidemiology of Nursing Home Associated Invasive Pneumococcal Disease After Implementation of a Routine Pediatric PCV13 Program in Ontario, Canada.
    Allison Mcgeer, MD, MSc; Karen Green, MSc, RN; Wallis Rudnick, MSc.; Agron Plevneshi, BSc; Sylvia Pong-Porter, MLT; Jeff Li, BSc
    Actinomyces in Blood: Is it Clinically Significant or Insignificant?
    Siddhant Datta, MD; Megan Soliman, MD; Maryrose Laguio, MD
    Long-term Impacts of Infectious Diseases Consultation on Post-Discharge Outcomes for Patients with Staphylococcus aureus Bacteremia: a Cohort Analysis in Veterans Health Administration
    Michihiko Goto, MD, MSCI; Marin Schweizer, PhD; Daniel Livorsi, MD, MSc; Eli Perencevich, MD, MS, FIDSA, FSHEA; Kelly Richardson, PhD; Brice Beck, MA; Bruce Alexander, PharmD; Michael Ohl, MD, MSPH
    Epidemiologic Evaluation of Rothia Bacteremia-A Single Cancer Center Three Year Experience
    Kristy Shaeer, PharmD; Anteneh Addisu, MD, PhD; Sowmya Nanjappa, MD; John Greene, MD, FACP
    A Simplified Pitt Bacteremia Score (qPitt) to Predict Mortality in Patients with Gram-Negative Bloodstream Infection
    Sarah E. Battle, MD; Matthew R. Augustine, BS; P. Brandon Bookstaver, PharmD, FCCP, FIDSA, AAHIVP; Christopher M. Watson, MD; William Owens, MD; Joseph Kohn, PharmD, BCPS; Larry M. Baddour, MD; Majdi N. Al-Hasan, MBBS
    Posters
  • IDWeek 2017 Poster_Final.pdf (452.2 kB)
  • Clostridium ramosum (C. ramosum) Bacteremia: Single Center Study
    Lakshmi Asritha Gollapudi, M.D; Roshni Narurkar, M.D; Guiqing Wang, MD/PhD; Abhay Dhand, M.D
    Comparative Efficacy of Oral Fluoroquinolones and Beta-lactams as Stepdown Therapy for Enterobacteriaceae Bloodstream Infection
    Nicholas Mercuro, PharmD; Patricia Stogsdill, MD; Minkey Wungwattana, Pharm.D., BCPS (AQ-ID)
    Evaluating Adherence to National Guidelines and Clinical Outcomes in Staphylococcus aureus Bacteremia
    Darcy Wooten, MD, MS; Gregory Seymann, MD; Beacher Schneider, MD; Melanie McCauley, MD; Randy Taplitz, MD; Michele Ritter, MD; Saima Aslam, MD, MS
    Posters
  • SAB poster.pdf (177.5 kB)
  • Prosthetic Valve Endocarditis
    Zaid Al-Rufaye, MD; Sherwin Chiu, medical student; Mohammed Abdulhaleem, MD; Mohanad Hasan, MD; Sayf Altabaqchali, MD; Farrah Ibrahim, MD FACP; Ali Hassoun, MD FIDSA FACP
    Outcome Based Study of Carbapenem Use Relative to ESBLs (OBSCURE)
    Otavio Pereira Rodrigues, MD; Matthew Sims, MD, PhD
    Staphylococcus aureus Bacteremia (SAB) Management in a Large Metropolitan Integrated Health Region: Quality of Care Determinants (QoCD)
    John Lam, MD; Stephen Robinson, MD; Daniel Gregson, MD; Ranjani Somayaji, M.D.; Lisa Welikovitch, MD; John Conly, MD; Michael Parkins, MD
    Clinical Outcomes with Penicillin Versus Alternative Beta-Lactams in the Treatment of Penicillin-Susceptible Staphylococcus aureus Bacteremia
    Megan Shah, PharmD; Lynn Wardlow, PharmD, MBA, BCPS-AQ ID; Kurt Stevenson, MD, MPH, FSHEA; Kelci Haydocy, MPH; Erica Reed, PharmD, BCPS-AQ ID
    A Multicenter Evaluation of Cardiovascular Implantable Electronic Device (CIED) Infection Management
    Pamela Foral, Pharm.D., BCPS; Jeremiah Saunders, Pharm.D.; Estella Davis, Pharm.D., BCPS; Katie Packard, Pharm.D., BCPS, AACC; Katie Duggins, Pharm.D., BCPS; Michaela Hrdy, Pharm.D.; John Horne, MD; Christopher Destache, PharmD
    Posters
  • CIED_poster_ID_week.pdf (540.8 kB)
  • Staphylococcus aureus Bacteremia in a Secondary Level Spanish Hospital: Clinical implications of Vancomycin MIC≥2 Isolates.
    Gabriela Abelenda, MD; María Dolores Corbacho, MD; Ruth Núñez, MD; Miguel Cervero, PhD
    Posters
  • IDWEEK.versionuploaded.jpg (207.8 kB)
  • Clinical Presentation of Infective Endocarditis in the Early 21st Century: A Descriptive Study
    Sampurna Shakya, MD; Syed Hussain, MD; Steven Gordon, MD; Gosta Pettersson, MD, PhD; Nabin Shrestha, MD, MPH, FIDSA, FSHEA
    Prevalence and Factors associated with Mortality Rate in Infective Endocarditis: a 10 Year Experience at a University Hospital, Thailand
    Chotirat Nakaranurack, Specialized Fellowship in infectious disease pharmacotherapy; Gompol Suwanpimolkul, MD, MSc.
    Posters
  • IdSA presentation.pdf (337.9 kB)
  • Management and Outcomes of Cardiovascular Implantable Electronic Device Infections due to Gram-Negative Bacteria
    Zerelda Esquer Garrigos, MD; Prakhar Vijayvargiya, MD; Eugene M. Tan, MD; Omar Abu Saleh, MD; Saira Farid, MD; Ana Paim, MD; Larry M. Baddour, MD; M. Rizwan Sohail, MD
    Posters
  • ID week CIED final.pdf (37.4 kB)
  • Risk Factors for Mortality in Patients with Aeromonas Bacteremia
    Heun Choi, MD; Jung Ju Kim, MD; Jinnam Kim, MD; Hye Seong, MD; Se Ju Lee, MD; Wooyong Jeong, MD; In Young Jeong, MD; Su Jin Jeong, MD/PhD; Nam Su Ku, MD, PhD; Sang Hoon Han, MD; Jun Yong Choi, MD, PhD; Young Goo Song, MD, PhD; June Myung Kim, MD, PhD
    Evaluation of a Prolonged β-Lactam Antibiotic Infusion Policy on Clinical Outcomes in Patients with Pseudomonas aeruginosa Bacteremia
    Megan E. Barra, PharmD, BCPS; Jillian Dempsey, PharmD, BCPS; Eleanor Broadbent, BS; Nour Ismail, MD; Obadah Aloum, MBBS; Paul Szumita, PharmD, BCPS, BCCCP, FCCM, FASHP; Sophia Koo, MD, FIDSA; David W. Kubiak, PharmD, BCPS {AQ ID}
    Is the prognosis of septic shock different in case of malignancies?
    Fabrice Camou, MD; Nahema Issa, MD; Gaelle Mourissoux, MD; Olivier Guisset, MD
    Posters
  • POSTER CS IDWEEK 2017bis.pdf (580.8 kB)
  • Sources and Microbiology of Bloodstream Infections Among Left Ventricular Assist Device Recipients
    John O'horo, MD, MPH; Alan Wright, MD, FIDSA, FSHEA; John Stulak, MD; Larry M. Baddour, MD; M. Rizwan Sohail, MD
    Resurgence of Methicillin Susceptible (MSSA) Staphylococcus aureus (SA) in Bacteremia.
    Riad Khatib, MD; Leonard Johnson, MD; Kathleen Riederer, MT
    Posters
  • Slide1.GIF (919.7 kB)
  • Infective Endocarditis: What Does the Surgical Specimen Teach us? A Real Life Experience
    Mustafa Hasan, MD; Sagy Grinberg, MD; Eliahu Bishburg, MD, FIDSA; Sandhya Nagarakanti, MD; Safiyya Quintiliani, MD
    Outcomes after exclusive medical treatment for prosthetic valve endocarditis
    Fabrice Camou, MD; Marina Dijos, MD; Laurent Barandon, MDPhD; Carine Greib, MD; Olivia Peuchant, MD, PhD; Gaetane Wirth, MD; Marion Laine, MD; Nahema Issa, MD
    Posters
  • POSTER PVE IDWEEK 2017b.pdf (581.1 kB)
  • Polymicrobial Bloodstream Infections due to Intra-Abdominal Infections: A Retrospective Analysis of 158 Cases at a Tertiary Care Hospital in Japan
    Aki Sakurai, MD; Takahiro Matsuo, MD; Nobuyoshi Mori, MD; Osamu Takahashi, MD, MPH, PhD; Keiichi Furukawa, MD
    Invasive Staphylococcus Epidermidis Isolates are Highly Clonal and Distinct from Commensal Strains: Time for a New Paradigm in Infection Control?
    Rita Wilson Dib, MD; Yazan Numan, MD; Xiqi Li, MS; Awdhesh Kalia, Ph.D.; Issam Raad, MD; Samuel A. Shelburne, MD, PhD
    Posters
  • IDSA poster 2017 staph epi.pdf (700.2 kB)
  • Infective Endocarditis due to Nutritionally Variant Streptococci (Granulicatella and Abiotrophia): The Cleveland Clinic Experience
    Tannaz Asadi, MD; Nabin Shrestha, MD, MPH, FIDSA, FSHEA; Gosta Pettersson, MD, PhD; Jose Navia, MD; Steven Gordon, MD; Thomas Fraser, MD; Susan J. Rehm, MD, FIDSA
    Posters
  • 2017 IDSA poster(3).pdf (700.6 kB)
  • Long-Term Prognosis of Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia at a Tertiary Care Hospital in the United States (US)
    Alexander J. Lepak, M.D.; Meghan Brennan, MD; Joseph McBride, MD; Erin McCreary, PharmD, BCPS; Derrick Chen, MD
    Role of Adjunctive Clindamycin in Beta-lactam-treated Cases of Invasive Group A Streptococcal Bacteremia: A Propensity score-matched analysis from 134 US hospitals
    Sameer S. Kadri, MD, MS; Ahmed Babiker, MBBS; Yi Ling Lai, MPH; Xiaobai Li, PhD; Sadia Hussain, MD; Jeffrey Strich, MD; John P. Dekker, M.D., Ph.D.; Robert L. Danner, MD
    Polymyxin Monotherapy versus Combination Therapy for the Treatment of Carbapenem-Resistant Enterobacteriaceae Bloodstream Infection: A National Cohort Study
    Nicholas S. Britt, PharmD, MS; Nimish Patel, PharmD, PhD; Emily M. Potter, PharmD; Molly E. Steed, PharmD

    CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.